Sun Pharma’s UNLOXCYT gets NCCN Category 2A recommendation for locally advanced skin cancer

The updated recommendation adds to the drug’s existing Category 2A designation for metastatic cutaneous squamous cell carcinoma
Read the full report on Indianpharmapost
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Indianpharmapost
- Published
- Wednesday, 21 October 2026, 12:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Indianpharmapost with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.




